Item 8.01 Other Events.
On September 21, 2021, Hancock Jaffe Laboratories, Inc. (the "Company") issued a
press release announcing that the Company (i) will be changing its name to
enVVeno Medical Corporation and ticker symbols to NASDAQ: NVNO and NVNOW,
effective October 1, 2021, (ii) has updated its development strategy to focus on
venous disease and advancement of the VenoValve® and (iii) has initiated
development of a second product for the treatment of venous disease; expected to
be unveiled in mid-2022. A copy of the press release issued by the Company is
attached as Exhibit 99.1 and is incorporated by reference into this Item 8.01.
Item 9.01 Financial Statements and Exhibits.
Set forth below is a list of Exhibits included as part of this Current Report.
99.1 Press Release
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
© Edgar Online, source Glimpses